Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis

Annals of the Rheumatic Diseases

Volumn 72, Issue 7, 2013, Pages 1255-1258

  Beyer, Christian ^a   Reichert, Helena ^a   Akan, Hümeyra ^a   Mallano, Tatjana ^a   Schramm, Amelie ^a   Dees, Clara ^a   Palumbo Zerr, Katrin ^a   Lin, Neng Yu ^a   Distler, Alfiya ^a   Gelse, Kolja ^b   Varga, John ^c   Distler, Oliver ^d   Schett, Georg ^a   Distler, Jor̈g H W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; ICG 001; PKF 118 310; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFIBROTIC ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; GENE OVEREXPRESSION; MOUSE; MYOFIBROBLAST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SKINFOLD THICKNESS; TOXICITY TESTING; WNT SIGNALING PATHWAY;

FIBROBLASTS; SYSTEMIC SCLEROSIS; TREATMENT;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; DISEASE MODELS, ANIMAL; FIBROSIS; MICE; MICE, INBRED DBA; PYRIMIDINONES; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES; TREATMENT OUTCOME; TRIAZINES; WNT SIGNALING PATHWAY;

EID: 84878406860     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202544     Document Type: Article

References (20)

1. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210. (Pubitemid 351160157)
2. Beyer C, Schramm A, Akhmetshina A, et al. beta-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis. Ann Rheum Dis 2012;71:761-7.
3. Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 2012;3:735.
4. Bergmann C, Akhmetshina A, Dees C, et al. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Ann Rheum Dis 2011;70:191-8.
5. Wei J, Melichian D, Komura K, et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum 2011;63:1707-17.
6. Colwell AS, Krummel TM, Longaker MT, et al. Wnt-4 expression is increased in fibroblasts after TGF-beta1 stimulation and during fetal and postnatal wound repair. Plast Reconstr Surg 2006;117:2297-301. (Pubitemid 44324270)
7. Konigshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009;119:772-87.
8. Surendran K, McCaul SP, Simon TC. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol 2002;282:F431 -441.
9. Wei J, Fang F, Lam AP, et al. Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum 2012;64:2734-45.
10. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
11. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67.
12. van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009;136:3205-14.
13. Beyer C, Schett G, Distler O, et al. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum 2010;62:2831-44.
14. Dees C, Akhmetshina A, Zerr P, et al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 2011;208:961-72.
15. Hao S, He W, Li Y, et al. Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 2011;22:1642-53.
16. Henderson WR Jr, Chi EY, Ye X, et al. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010;107:14309-14.
17. Hallett RM, Kondratyev MK, Giacomelli AO, et al. Small molecule antagonists of the Wnt/beta-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer. PLoS One 2012;7:e33976.
18. Verkaar F, Zaman GJ. New avenues to target Wnt/beta-catenin signaling. Drug Discov Today 2011;16:35-41.
19. Beyer C, Distler JH. Morphogen pathways in systemic sclerosis. Curr Rheumatol Rep 2013;15:299.
20. Distler A, Deloch L, Huang J, et al. Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling. Ann Rheum Dis Published Online First 12 Nov 2012. doi:10.1136/annrheumdis-2012-202275